STOCK TITAN

FOXO TECHNOLOGIES - FOXO STOCK NEWS

Welcome to our dedicated page for FOXO TECHNOLOGIES news (Ticker: FOXO), a resource for investors and traders seeking the latest updates and insights on FOXO TECHNOLOGIES stock.

FOXO Technologies Inc (FOXO) operates at the intersection of epigenetic science and artificial intelligence, delivering innovative solutions for life insurance underwriting and longevity research. This page serves as the definitive source for official company announcements, financial updates, and strategic developments.

Investors and industry observers will find curated coverage of earnings reports, technology partnerships, regulatory milestones, and acquisition activity. Our repository includes press releases related to FOXO Labs' biomarker discoveries and FOXO Life's insurance product innovations, providing insight into how epigenetic data transforms risk assessment models.

Key areas of focus include updates on AI-driven health analytics, strategic expansions into community health initiatives, and advancements in DNA methylation testing methodologies. All content is sourced directly from verified corporate communications to ensure reliability.

Bookmark this page for real-time access to FOXO's evolving role in reshaping insurance through longevity science. Check regularly for critical updates that demonstrate the company's progress in translating epigenetic research into commercial applications.

Rhea-AI Summary

FOXO Technologies has secured up to $2.8 million in Senior Notes from an institutional investor to fund the acquisition of Myrtle Recovery Centers and provide additional working capital. The acquisition, along with the planned purchase of Scott County Community Hospital, is expected to be transformative for the company, which reported combined unaudited net revenue of approximately $18.7 million and net income of $5.2 million for 2023. Interim CEO Mark White expressed optimism about the strategic fit of these acquisitions with FOXO's epigenetic and AI-based solutions. Further details are available in the Company's Form 8-K filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.67%
Tags
-
Rhea-AI Summary

FOXO Technologies has received a non-compliance notice from the NYSE American due to overdue listing fees exceeding 180 days. The company missed the June 7, 2024 deadline for payment but has since settled the fees. FOXO's Interim CEO, Mark White, attributed the delay to short-term capital allocation strategies, including planned acquisitions expected to boost cash flow. Despite the delinquency, FOXO aims to regain compliance with NYSE standards soon. The company is now under the procedures outlined in Section 1009 of the NYSE Company Guide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.07%
Tags
none
-
Rhea-AI Summary

On June 14, 2024, FOXO Technologies announced two share exchange agreements with Rennova Health to acquire healthcare operations. The deals involve Myrtle Recovery Centers and Scott County Community Hospital (doing business as Big South Fork Medical Center). Myrtle Recovery Centers will be exchanged for $500,000 in FOXO common stock, while Scott County Community Hospital will be exchanged for $20 million in convertible preferred stock. These acquisitions are expected to generate significant cash flow for FOXO, with the acquired entities reporting $18.7 million in net revenue and $5.2 million in net income for 2023. The integration aims to leverage FOXO’s epigenetic technology in community health and addiction recovery, potentially expanding market reach and improving patient outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.92%
Tags
Rhea-AI Summary
FOXO Technologies Inc. received a Notice of Non-Compliance from NYSE for failing to file its Annual Report on Form 10-K by the due date. Despite challenges, the company is committed to regaining compliance, improving financial systems, and advancing transformative transactions to drive shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
none
-
Rhea-AI Summary
FOXO Technologies Inc. announces a proposed merger with M2i Global, Inc. to focus on securing the nation's supply of critical materials and resources. The merger aims to develop a global value supply chain for critical minerals for the U.S. government and free trade partners, as well as create a strategic mineral reserve in partnership with the U.S. Federal Government. The collaboration brings together extensive experience, knowledge, and resources to drive value for shareholders and enhance operational efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.66%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. appoints Francis Colt deWolf to its Board of Directors, bringing over 20 years of experience in the financial services sector. The Company also received a notice of noncompliance from NYSE Regulation regarding its audit committee composition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
management
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) has announced the formalization of its collaboration with KR8.ai Inc. and the exclusive license to KR8's AI-based software to support the development and commercial launch of its new health and wellness offering - the VITHAR™ AI Health Coach. The company aims to provide personalized health and wellness recommendations by leveraging epigenetic data, genetic insight, and growing patent estate with AI-driven analytic software and proprietary algorithms. The goal is to capture a meaningful share of the Health and Fitness App Market, which is projected to reach $35.7 billion by 2030, through a cost-effective go-to-market strategy. The new app will require users to send a saliva or blood sample, and the technology will combine this information with user health stats, as well as peer-reviewed clinical studies and other verified health resources to provide customized AI-driven health recommendations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.49%
Tags
AI
-
Rhea-AI Summary
FOXO Technologies Inc. (Ticker: FOXO) received a notice of noncompliance from NYSE Regulation due to the failure to timely file the Company’s Form 10-Q for the period ended September 30, 2023. The Company is committed to regaining compliance with the NYSE American’s continued listing requirements and has taken steps to enhance its financial infrastructure and ensure the highest standards of corporate governance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
-
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) expects a reduction in losses of over $10 million for the third quarter of 2023 compared to the prior quarter. The company provided a business update on the planned commercial rollout of its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, and anticipates reporting financial results for the three and nine months ended September 30, 2023. The reduction in losses includes cash operational cost reductions in excess of $2.1 million over the second quarter of 2023. The company also plans to leverage social media influencers to enhance the commercial launch of the VITHAR AI Health Coach and expects annualized cost savings in excess of 52% for 2023, aiming to maintain a lean operating infrastructure to drive profitability following the commercial launch.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.82%
Tags
AI
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. The Company has a six-month initial cure period to file the Form 10-Q with the SEC, with the possibility of an additional six-month cure period if needed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.72%
Tags
none
FOXO TECHNOLOGIES

NYSE:FOXO

FOXO Rankings

FOXO Stock Data

3.01M
21.24M
9.9%
2.69%
8%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
MINNEAPOLIS